Defending the ‘middlemen’ in the battle on drug prices – As the middlemen, PBMs are being demonized by both the drug industry & President Trump.

Pharmacy benefit managers (PBM) ? the ?middlemen? in drug price negotiations ? are under attack, and, for the past 15 years, Mark Merritt has been the point man in charge of defending them.

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website,

View all posts by Robert Zinn →